1-5 of 5
Brigitte Pautard, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

Andre Baruchel, PhD, MD, Arnaud Petit, Thierry Leblanc, Gérard Michel, Yves Perel, MD, PhD, Francoise Mechinaud, MD, Virginie Gandemer, Claudine Schmitt, MD, Pascale Schneider, Benoit Brethon, MD, Anne Auvrignon, Caroline Thomas, M.D., Geneviève Margueritte, Christiane Vermylen, MD, PhD, Odile Lejars, MD, Isabelle Pellier, Claire Berger, MD, Gérard Couillault, Catherine Paillard, Christian Berthou, MD, Christophe Piguet, MD, Brigitte Pautard, MD, Jean Soulier, MD, PhD, Nathalie Grardel, Kheira Beldjord, Marie-Francoise Auclerc, Elizabeth Macintyre, MD, PhD, Jean-Michel Cayuela, PhD, Sylvie Chevret, Guy Leverger, MD
Journal: Blood
Blood (2012) 120 (21): 135.
https://doi.org/10.1182/blood.V120.21.135.135
Published: 2012
Journal Articles

A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study

Susanne Holzhauer, MD, Christoph Bidlingmaier, MD, Carmen Escuriola Ettingshausen, MD, Susan Halimeh, MD, Alfonso Iorio, MD, Gili Kenet, MD, Brigitte Pautard, MD, Ulrike Nowak-Gottl, MD
Journal: Blood
Blood (2010) 116 (21): 710.
https://doi.org/10.1182/blood.V116.21.710.710
Published: 2010
Journal Articles

High-Dose Methotrexate Seems to Benefit Only to Standard-Risk BCP-ALL Patients with Good Early Response to Chemotherapy: Final Analysis of the FRALLE93B Study

Thierry Leblanc, MD, Judith Landman-Parker, MD, Marie-Françoise Auclerc, MD, Krystell Desseaux, Christiane Vermylen, MD, Claudine Schmitt, MD, Virginie Gandemer, MD, Odile Lejars, MD, Jean-Pierre Vannier, MD, François Demeocq, MD, Christian Berthou, MD, Gérard Couillault, MD, Brigitte Pautard, MD, Claire Berger, MD, Lionel De Lumley, MD, Marianne Debré, MD, Gérard Michel, MD, Yves Perel, MD, Guy Leverger, MD, Andre Baruchel, MD
Journal: Blood
Blood (2008) 112 (11): 10.
https://doi.org/10.1182/blood.V112.11.10.10
Published: 2008
Journal Articles

Immune Tolerance Induction by High Doses FVIII in Hemophilia A Patients with Inhibitor Does Not Require Deletion of FVIII-Specific T Cells.

Marc G. Jacquemin, MD, Renaud Lavend’homme, Ms, Thérèse Tinot, Ms, Kathelijne Peerlinck, MD, Jean Marie Saint-Remy, MD, Brigitte Pautard, MD
Journal: Blood
Blood (2006) 108 (11): 1029.
https://doi.org/10.1182/blood.V108.11.1029.1029
Published: 2006
Journal Articles

Evaluation of Minimal Residual Disease (MRD) by Quantification of TEL-AML1 Transcripts Is a Powerful Prognostic Tool in Children with T(12;21) Positive Acute Lymphoblastic Leukemia (ALL).

Jean-Michel Cayuela, PhD, Paola Ballerini, PhD, Marina Romeo, PhD, Vahid Asnafi, PhD, Marie-Francoise Auclerc, MD, Xavier Fund, PhD, Eric Delabesse, PhD, Christian Bastard, PhD, Jean Gabert, PhD, Jean-Pierre Vanier, MD, Odile Lejars, MD, Mariane Debre, MD, Brigitte Pautard, MD, Gerard Michel, MD, Thierry Leblanc, MD, Guy Leverger, MD, Sylvie Chevret, PhD, Elisabeth Macintyre, PhD, Andre Baruchel, MD, for the FRALLE group
Journal: Blood
Blood (2004) 104 (11): 322.
https://doi.org/10.1182/blood.V104.11.322.322
Published: 2004